![Angela Cacace](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 2 M $ as of 2026-05-30
Dr. Angela Cacace is a Chief Scientific Officer at Arvinas, Inc. Dr. Cacace was previously employed as a Neuroscience Director by Bristol Myers Squibb Co. She received her undergraduate degree from Fairfield University and a doctorate degree from The Trustees of Columbia University in The City of New York.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARVINAS, INC. 0.28% | 2026-05-10 | 182,966 ( 0.28% ) | 2 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| ARVINAS, INC. | Chief Tech/Sci/R&D Officer | 2024-06-16 |
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairfield University
 Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
